NCT01801644View on ClinicalTrials.gov

Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions
Bladder Cancer
Interventions
DRUG

gemcitabine plus cisplatin

gemcitabine 1000 mg/m2 on days 1,8,15 as a 30 minute infusion followed by cisplatin 70 mg/m2 on day 1 as an 2 hour infusion

Trial Locations (1)

1020

Barmherzige Brüder Vienna, Vienna

All Listed Sponsors
lead

Barmherzige Brüder Vienna

OTHER

NCT01801644 - Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer | Biotech Hunter | Biotech Hunter